Feedback / Questions
uliledlimab (TJD5) - I-Mab, Tracon Pharma
ragistomig (ABL503) - ABL Bio, I-Mab
https://www.globenewswire.com/news-release/2025/08/20/3136301/0/en/I-Mab-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
Aug 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next